| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
20/20 Biolabs, Inc.
13D
AIDX · 90138K101
|
16.8% |
3/10/2026
Event 3/3/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.